Buscar
Foxo Technologies Inc
FOXOAñadir a la lista de seguimiento
0.092USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
31.56KCap. mercado
PérdidaP/E TTM
Más Datos de Foxo Technologies Inc Compañía
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Información de Foxo Technologies Inc
Símbolo de cotizaciónFOXO
Nombre de la empresaFoxo Technologies Inc
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoMr. Seamus Lagan
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 11
Dirección477 South Rosemary Avenue
CiudadWEST PALM BEACH
Bolsa de valoresUS 'Other OTC' and Grey Market
PaísUnited States of America
Código postal33401
Teléfono16128000059
Sitio Webhttp://delwinds.com/
Símbolo de cotizaciónFOXO
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoMr. Seamus Lagan
Ejecutivos de Foxo Technologies Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.36%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bret Barnes
Mr. Bret Barnes
Director
Director
168.00
+0.36%
Mr. Mark K. White
Mr. Mark K. White
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
Chief Executive Officer and sole director of FOXO Labs Inc. and Director
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Chairman of the Board
Chairman of the Board
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Sylwia Hauman
Sylwia Hauman
Chief Financial Officer
Chief Financial Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Foxo Technologies Inc?
Los cinco principales accionistas de Foxo Technologies Inc son: Mr. Bret Barnes
¿Cuántas instituciones poseen acciones de Foxo Technologies Inc (FOXO)?
A fecha de 2026Q1, 29 instituciones poseen acciones de Foxo Technologies Inc, con un valor de mercado combinado de aproximadamente 249.32M, lo que representa el 6.78% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 249192775.00.